We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Miss
Deena
Harji
+44 1133438089
deena.harji@nhs.net
Miss
Niamh
McKigney
+44 1133438089
N.McKigney1@leeds.ac.uk
Miss
Niamh
McKigney
+44 1133438089
N.McKigney1@leeds.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Health-related quality of life and survivorship in locally recurrent rectal cancer
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Locally recurrent rectal cancer is cancer that returns close to the origin site following surgery. The extent of the burden that locally recurrent rectal cancer has on quality of life is poorly reported. Patients with advanced cancer value both survival and quality of life. Using only traditional clinical endpoints in advanced cancer settings is no longer valid and should be reported alongside patient-reported outcomes such as quality of life, in an attempt to present a more balanced outlook on treatments and management strategies.
There are many questionnaires that currently exist that are used to assess quality of life, however, these tools have not been validated specifically for patients with locally recurrent rectal cancer. Validation means checking that the questionnaire is applicable across relevant patient groups. The LRRC-QoL is a questionnaire that has been designed specifically to assess quality of life in patients with locally recurrent rectal cancer. The LRRC-QoL has been developed and validated in patients from the UK and Australia.
The aims of the study are:
- to translate and validate the LRRC-QoL into 13 different languages to aid international research in determining the quality of life outcomes in locally recurrent rectal cancer,
- to understand the impact of locally recurrent rectal cancer and its treatment on quality of life,
- to identify survivorship issues relevant to patients who have undergone treatment for locally recurrent rectal cancer and are disease-free,
- to compare the quality of life outcomes between different groups of patients with locally recurrent rectal cancer.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Patients with cognitive impairment2. Patients who are in remission from treatment of primary rectal cancer with no evidence of local recurrence3. Patients who are receiving treatment for distant metastatic disease following previous treatment of rectal cancer with no evidence of local recurrence
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Miss
Deena
Harji
+44 1133438089
deena.harji@nhs.net
Miss
Niamh
McKigney
+44 1133438089
N.McKigney1@leeds.ac.uk
Miss
Niamh
McKigney
+44 1133438089
N.McKigney1@leeds.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Leeds and funded by Bowel Research UK; Pelican Cancer Foundation.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 46607
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
